These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27745934)

  • 1. [Blood concentration of hydroxychloroquine in systemic lupus erythematosus care: Usefulness and limits].
    Costedoat-Chalumeau N; Tamirou F; Le Guern V; Blanchet B; Deligny C; Piette JC
    Rev Med Interne; 2017 Feb; 38(2):77-80. PubMed ID: 27745934
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is it necessary to monitor blood hydroxychloroquine concentrations in patients with systemic lupus erythematosus?].
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Lechat P; Piette JC
    Rev Med Interne; 2006 Sep; 27(9):655-7. PubMed ID: 16766090
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort.
    Geraldino-Pardilla L; Perel-Winkler A; Miceli J; Neville K; Danias G; Nguyen S; Dervieux T; Kapoor T; Giles J; Askanase A
    Lupus; 2019 Jun; 28(7):862-867. PubMed ID: 31122136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
    Noé G; Amoura Z; Combarel D; Lori L; Tissot N; Seycha A; Funck-Brentano C; Zahr N
    Ther Drug Monit; 2019 Aug; 41(4):476-482. PubMed ID: 30807538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Hammoud HA; Aymard G; Cacoub P; Francès C; Wechsler B; Huong du LT; Ghillani P; Musset L; Lechat P; Piette JC
    Arthritis Rheum; 2006 Oct; 54(10):3284-90. PubMed ID: 17009263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
    Yeon Lee J; Lee J; Ki Kwok S; Hyeon Ju J; Su Park K; Park SH
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):536-542. PubMed ID: 27390146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine blood assay as a marker of nonadherence in patients with systemic lupus erythematosus: comment on the article by Koneru et al.
    Costedoat-Chalumeau N; Amoura Z; Marra D; Piette JC
    Arthritis Rheum; 2008 Jan; 59(1):153; author reply 153-4. PubMed ID: 18163410
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood.
    Charlier B; Pingeon M; Dal Piaz F; Conti V; Valentini G; Filippelli A; Izzo V
    Biomed Chromatogr; 2018 Aug; 32(8):e4258. PubMed ID: 29669398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.
    Jallouli M; Galicier L; Zahr N; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Le Thi Huong D; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Leroux G; Cohen-Bittan J; Sellam J; Mariette X; Blanchet B; Hulot JS; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Arthritis Rheumatol; 2015 May; 67(8):2176-84. PubMed ID: 25989906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Aymard G; Leroux G; Marra D; Lechat P; Piette JC
    Ann Rheum Dis; 2007 Jun; 66(6):821-4. PubMed ID: 17324970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to treatment in systemic lupus erythematosus patients.
    Costedoat-Chalumeau N; Pouchot J; Guettrot-Imbert G; Le Guern V; Leroux G; Marra D; Morel N; Piette JC
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):329-40. PubMed ID: 24238690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment?
    Costedoat-Chalumeau N; Leroux G; Piette JC; Amoura Z
    Joint Bone Spine; 2010 Jan; 77(1):4-5. PubMed ID: 20022788
    [No Abstract]   [Full Text] [Related]  

  • 13. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.
    Al-Rawi H; Meggitt SJ; Williams FM; Wahie S
    Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine Hydroxychloroquine Blood Concentration Measurement in Systemic Lupus Erythematosus Reaches Adulthood.
    Costedoat-Chalumeau N; LE Guern V; Piette JC
    J Rheumatol; 2015 Nov; 42(11):1997-9. PubMed ID: 26523036
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important.
    Lee JY; Luc S; Greenblatt DJ; Kalish R; McAlindon TE
    Lupus; 2013 Apr; 22(5):541-2. PubMed ID: 23396569
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.
    Jolly M; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin DL; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Hulot JS; Arora S; Amoura Z; Piette JC; Costedoat-Chalumeau N;
    Lupus; 2016 Jun; 25(7):735-40. PubMed ID: 26876692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine in systemic lupus erythematosus.
    Costedoat-Chalumeau N; Amoura Z; Hulot JS; Lechat P; Piette JC
    Lancet; 2007 Apr; 369(9569):1257-1258. PubMed ID: 17434394
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry.
    Füzéry AK; Breaud AR; Emezienna N; Schools S; Clarke WA
    Clin Chim Acta; 2013 Jun; 421():79-84. PubMed ID: 23485647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
    Carmichael SJ; Day RO; Tett SE
    Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.